DNA activates human immune cells through a CpG sequence-dependent manner

Immunology

Volumn 97, Issue 4, 1999, Pages 699-705

  Bauer, M ^a   Heeg, K ^b   Wagner, H ^a   Lipford, G B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; DNA; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CPG ISLAND; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, SURFACE; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIVISION; CPG ISLANDS; DNA, BACTERIAL; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MONOCYTES; OLIGONUCLEOTIDES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0032810718     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00811.x     Document Type: Article

References (33)

1. 1. TOKUNAGA T., YAMAMOTO H., SHIMADA S. et al. (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72, 955.
2. 2. SHIMADA S., YANO O. & TOKUNAGA T. (1986) In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn J Cancer Res 77, 808.
3. 3. YAMAMOTO S., KURAMOTO E., SHIMADA S. & TOKUNAGA T. (1988) In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 79, 866.
4. 4. MESSINA J.P., GILKESON G.S. & PISETSKY D.S. (1991) Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 147, 1759.
5. 5. YAMAMOTO S., YAMAMOTO T., SHIMADA S. et al. (1992) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 36, 983.
6. 6. TOKUNAGA T., YANO O., KURAMOTO E. et al. (1992) Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 36, 55.
7. 7. KRIEG A.M., YI A.K., MATSON S. et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546.
8. 8. BIRD A.P. (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209.
9. 9. KLINMAN D.M., YAMSHCHIKOV G. & ISHIGATSUBO Y. (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158, 3635.
10. 10. LIPFORD G.B., HEEG K. & WAGNER H. (1998) Bacterial DNA as immune cell activator. Trends Microbiol 6, 496.
11. 11. STACEY K.J., SWEET M.J. & HUME D.A. (1996) Macrophages ingest and are activated by bacterial DNA. J Immunol 157, 2116.
12. 12. SATO Y., ROMAN M., TIGHE H. et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352.
13. 13. HALPERN M.D., KURLANDER R.J. & PISETSKY D.S. (1996) Bacterial DNA induces murinc interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol 167, 72.
14. 14. SPARWASSER T., MIETHKE T., LIPFORD G. et al. (1997) Bacterial DNA causes septic shock. Nature 386, 336.
15. 15. LIPFORD G.B., SPARWASSER T., BAUER M. et al. (1997) Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 27, 3420.
16. 16. CHANCE J.H., HOOKER N.A., MILDENSTEIN K.L., KRIEG A.M. & COWDERY J.S. (1997) Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 84, 185.
17. 17. ROMAN M., MARTIN-OROZCO E., GOODMAN J.S. et al. (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3, 849.
18. 18. SPARWASSER T., KOCH E.S., VABULAS R.M. et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28, 2045.
19. 19. LIPFORD G.B., BAUER M., BLANK C., RETTER R., WAGNER H. & HEEG K. (1997) CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 27, 2340.
20. 20. BALLAS Z.K., RASMUSSEN W.L. & KRIEG A.M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157, 1840.
21. 21. YI A.K., CHACE J.H., COWDERY J.S. & KRIEG A.M. (1996) IFN-gamma promotes II.-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol 156, 558.
22. 22. BENDIGS S., SALZER U., LIPFORD G.B., WAGNER H. & HEEG K. (1999) CpG-oligodeoxynucleotides costimulate primary T cells in the absence of APC. Eur J Immunol 29, 1290.
23. 23. DAVIS H.L., WEERANTA R., WALDSCHMIDT T.J., TYGRETT L., SCHORR J. & KRIEG A.M. (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160, 870.
24. 24. CHU R.S., TARGONI O.S., KRIEG A.M., LEHMANN P.V. & HARDING C.V. (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186, 1623.
25. 25. SUN S., KISHIMOTO H. & SPRENT J. (1998) DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 187, 1145.
26. 26. ZIMMERMANN S., EGETER O., HAUSMANN S. et al. (1998) CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine łeishmaniasis. J Immunol 160, 3627.
27. 27. KLINE J.N., WALDSCHMIDT T.J., BUSINGA T.R. et al. (1998) Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160, 2555.
28. 28. YAMAMOTO T., YAMAMOTO S., KATAOKA T., KOMURO K., KOHASE M. & TOKUNAGA T. (1994) Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res 85, 775.
29. 29. BRANDA R.F., MOORE A.L., HONG R., MCCORMACK J.J., ZON G. & CUNNINGHAM-RUNDLES C. (1996) B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Clin Immunol Immunopathol 79, 115.
30. 30. LIANG H., NISHIOKA Y., REICH C.F., PISETSKY D.S. & LIPSKY P.E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98, 1119.
31. 31. ULMER A.J., FEIST W., HEINF H. et al. (1992) Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 1251-lipopolysaccharide. Infect Immun 60, 5145.
32. 32. MACFARLANE D.E. & MANZEL L. (1998) Antagonism of immunostimulatory CpG-oligonucleotides by quinicrine, chloroquine, and structurally related compounds. J Immunol 160, 1122.
33. 33. HÄCKER H., MISCHAK M., MIETHKE T. et al. (1998) CpG-DNA specific activation of antigen presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17, 6230.